GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shelter Pharma Ltd (BOM:543963) » Definitions » Net Income From Continuing Operations

Shelter Pharma (BOM:543963) Net Income From Continuing Operations : ₹84.0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Shelter Pharma Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Shelter Pharma's net income from continuing operations for the six months ended in Mar. 2024 was ₹42.8 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Mar. 2024 was ₹84.0 Mil.

Shelter Pharma Net Income From Continuing Operations Historical Data

The historical data trend for Shelter Pharma's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shelter Pharma Net Income From Continuing Operations Chart

Shelter Pharma Annual Data
Trend Mar21 Mar22 Mar23 Mar24
Net Income From Continuing Operations
-2.37 25.06 70.51 84.04

Shelter Pharma Semi-Annual Data
Mar21 Mar22 Sep22 Mar23 Sep23 Mar24
Net Income From Continuing Operations Get a 7-Day Free Trial - 23.99 28.07 41.20 42.84

Shelter Pharma Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Mar. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹84.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shelter Pharma (BOM:543963) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shelter Pharma Ltd (BOM:543963) » Definitions » Net Income From Continuing Operations
Comparable Companies
NSE:WALPAR BOM:530057 NSE:JFLLIFE BOM:511523 BOM:537253 BOM:542678 BOM:538965 BOM:524703 NSE:VILINBIO BOM:542248 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
Mistry Chambers, Khanpur, Ahmedabad, GJ, IND, 380001
Website
https://www.shelter.co.in
Shelter Pharma Ltd focuses in manufacturing herbal products with well-built presence in Human Pharma as well as Veterinary space. It is present in most of non-critical segment of Human as well as Veterinary Pharma through its well spread portfolio. Its products include Tablets, syrups, Baby drops, Barley Water, Oils, Powders, Ointments and Etc.

Shelter Pharma (BOM:543963) Headlines

No Headlines